Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaroslav Hubacek

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|May 16, 2002
Is the CD14 receptor gene a marker for smoking dependence?Jaroslav Hubacek, Jan Pitha, Zdena Skodova, et al.
Journal of the American College of Cardiology|February 11, 2003
Effect of chelation therapy on endothelial function in patients with coronary artery disease: PATCH substudyTodd J Anderson, Jaroslav Hubacek, D George Wyse, et al.
Cureus|February 2, 2018
Does Frequency of ST-Segment Elevation Myocardial Infarction Presentation Impact Quality of Care?Alex N Mazurek, Paul R Atkinson, Jaroslav Hubacek, et al.
Atherosclerosis|November 24, 2012
Niacin improves lipid profile but not endothelial function in patients with coronary artery disease on high dose statin therapyAndrew C Philpott, Jaroslav Hubacek, Yichun C Sun, et al.
The Canadian Journal of Cardiology|December 23, 2004
Rationale and design of the Glitazones and the Endothelium (GATE) study: evaluation of rosiglitazone on endothelial function in patients with diabetesJaroslav Hubacek, Subodh Verma, Lana Shewchuk, et al.
The Canadian Journal of Cardiology|February 14, 2009
Prognostic implications of C-reactive protein and troponin following percutaneous coronary interventionJaroslav Hubacek, Rashpal S Basran, Fiona M Shrive, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|July 10, 2010
Predictors of infection after pulmonary endarterectomy for chronic thrombo-embolic pulmonary hypertensionPavel Maruna, Jan Kunstyr, Katerina M Plocova, et al.
The Canadian Journal of Cardiology|February 15, 2008
Outcomes of revascularization strategies for two-vessel coronary artery disease involving the proximal left anterior descending artery in an era of improved pharmacotherapy and stentingJaroslav Hubacek, Sunil Kalla, P Diane Galbraith, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 8, 2006
Effects of folinic acid on forearm blood flow in patients with end-stage renal diseaseTodd J Anderson, Yiu-Hui Sun, Jaroslav Hubacek, et al.
American Heart Journal|January 31, 2006
External validation of a percutaneous coronary intervention mortality prediction model in patients with acute coronary syndromesJaroslav Hubacek, P Diane Galbraith, Min Gao, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|May 16, 2002
Is the CD14 receptor gene a marker for smoking dependence?Jaroslav Hubacek, Jan Pitha, Zdena Skodova, et al.
Journal of the American College of Cardiology|February 11, 2003
Effect of chelation therapy on endothelial function in patients with coronary artery disease: PATCH substudyTodd J Anderson, Jaroslav Hubacek, D George Wyse, et al.
Cureus|February 2, 2018
Does Frequency of ST-Segment Elevation Myocardial Infarction Presentation Impact Quality of Care?Alex N Mazurek, Paul R Atkinson, Jaroslav Hubacek, et al.
Atherosclerosis|November 24, 2012
Niacin improves lipid profile but not endothelial function in patients with coronary artery disease on high dose statin therapyAndrew C Philpott, Jaroslav Hubacek, Yichun C Sun, et al.
The Canadian Journal of Cardiology|December 23, 2004
Rationale and design of the Glitazones and the Endothelium (GATE) study: evaluation of rosiglitazone on endothelial function in patients with diabetesJaroslav Hubacek, Subodh Verma, Lana Shewchuk, et al.
The Canadian Journal of Cardiology|February 14, 2009
Prognostic implications of C-reactive protein and troponin following percutaneous coronary interventionJaroslav Hubacek, Rashpal S Basran, Fiona M Shrive, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|July 10, 2010
Predictors of infection after pulmonary endarterectomy for chronic thrombo-embolic pulmonary hypertensionPavel Maruna, Jan Kunstyr, Katerina M Plocova, et al.
The Canadian Journal of Cardiology|February 15, 2008
Outcomes of revascularization strategies for two-vessel coronary artery disease involving the proximal left anterior descending artery in an era of improved pharmacotherapy and stentingJaroslav Hubacek, Sunil Kalla, P Diane Galbraith, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 8, 2006
Effects of folinic acid on forearm blood flow in patients with end-stage renal diseaseTodd J Anderson, Yiu-Hui Sun, Jaroslav Hubacek, et al.
American Heart Journal|January 31, 2006
External validation of a percutaneous coronary intervention mortality prediction model in patients with acute coronary syndromesJaroslav Hubacek, P Diane Galbraith, Min Gao, et al.
Pageof 2